Novel Dynamic Outcome Indicators and Clinical Endpoints in Myelodysplastic Syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT Project Perspective

Overview

Journal Haematologica

Specialty Hematology

Date 2020 Oct 15

PMID 33054132

Citations 7

Authors

Theo de Witte

Luca Malcovati

Pierre Fenaux

David Bowen

Argiris Symeonidis

Moshe Mittelman

Reinhard Stauder

Guillermo Sanz

Jaroslav cermak

Saskia Langemeijer

Eva Hellstrom-Lindberg

Ulrich Germing

Mette Skov Holm

Krzysztof Madry

Aurelia Tatic

Antonio Medina Almeida

Aleksandar Savic

Inga Mandac Rogulj

Raphael Itzykson

Marlijn Hoeks

Hege Gravdahl Garelius

Dominic Culligan

Ioannis Kotsianidis

Lionel Ades

Arjan A van de Loosdrecht

Corine van Marrewijk

Ge Yu

Simon Crouch

Alex Smith

Affiliations

Soon will be listed here.

Citing Articles

Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower-risk myelodysplastic syndromes.

Rombaut D, Sandmann S, Tekath T, Crouch S, de Graaf A, Smith A Hemasphere. 2025; 9(1):e70073.

PMID: 39850648 PMC: 11754767. DOI: 10.1002/hem3.70073.

Metabolic dysregulation in myelodysplastic neoplasm: impact on pathogenesis and potential therapeutic targets.

Zhou H, Xiang W, Zhou G, Rodrigues-Lima F, Guidez F, Wang L Med Oncol. 2024; 42(1):23.

PMID: 39644425 DOI: 10.1007/s12032-024-02575-3.

MDS patient registries - achievements and challenges.

Steinmetz T, Totzke U, Kasprzak A, Schmitz S, Gattermann N, Germing U Ann Hematol. 2024; 103(12):4913-4930.

PMID: 39174754 DOI: 10.1007/s00277-024-05925-3.

Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML.

Chatzilygeroudi T, Chondrou V, Boers R, Siamoglou S, Athanasopoulou K, Verigou E Clin Epigenetics. 2024; 16(1):79.

PMID: 38879530 PMC: 11180405. DOI: 10.1186/s13148-024-01687-x.

Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.

Stojkov I, Conrads-Frank A, Rochau U, Arvandi M, Koinig K, Schomaker M Blood Adv. 2023; 7(12):2772-2783.

PMID: 36607832 PMC: 10275700. DOI: 10.1182/bloodadvances.2022008360.